Bio-drugs are also referred as biomedicine, Western medicine, mainstream medicine, or conventional medicine. It is a branch of medical science that applies biological and physiological principles to clinical practice. Bio-drugs are based on standardized, evidence-based treatment validated through biological research, with the treatment administered through formally trained doctors, nurses, and other such licensed practitioners.
It includes many other biomedical disciplines and areas of specialty that contain the "bio" prefix such as molecular biology, biotechnology, biochemistry, embryology, cell biology, Nanobiotechnology, biological engineering, laboratory medical biology, genetics, cytogenetics, gene therapy, systems biology, bioinformatics, biostatistics, microbiology, anatomy, toxicology, neuroscience, parasitology, virology, immunology, pathology, physiology, and many that usually concern with life sciences as applied to medicine.
A biomolecule is also known as a biological molecule. It is a used term for molecules present in organisms that are essential to one or more typically biological processes, such as cell division, morphogenesis, or development. It also includes large macromolecules such as carbohydrates, proteins, lipids, and nucleic acids, as well as small molecules such as natural products primary metabolites, secondary metabolites.
The four major types of biomolecules are carbohydrates, lipids, nucleic acids, and proteins.
In other terms, Biotherapeutics are also called biologicals. Biotherapeutics are drug therapy products, where the active ingredient is extracted from a biological source. These products include recombinant proteins and hormones, growth factors, monoclonal antibodies cytokines, gene therapy products, gene-silencing/editing therapies, vaccines, cell-based products, tissue-engineered products, and stem cell therapies.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia